In recent years, medical research and development has uncovered the medical benefits of mesenchymal stem cells and demonstrated their value in therapies for a variety of medical conditions. The data from years of research, IRBs and patient results world wide is providing evidence of this.
There are however, many stem cell therapies that are not being performed under IRBs. One example is the use of frozen umbilical cord stem cells. In the U.S., providers of these types of stem cells are required to sterilize them with irradiation. This actually kills the stem cells. Over a period of several years, we have regularly examined samples of sterilized umbilical cord stem cells under the microscope, with a NucleoCounter Cell Counter and observed no live stem cells. Also, when we attempted to grow cord cells, no growth was observed. Other sources of mesenchymal stem cells such bone marrow produce limited quantities of live mesenchymal stem cells which translate into limited results when used for joint and spinal therapy.
The board certified physicians at Pangenics Regenerative Center are currently participating in IRBs that are documenting all of the stem cell therapies performed and the results for every patient. And these documented results clearly verify that the stem cell therapies we are performing is improving the joint and back medical conditions in the majority of our patients. And we are proud that after over a decade of tracking our patients, there have been no serious complications recorded.